Jointown Pharmaceutical Group Co Ltd (600998)

Currency in CNY
5.42
-0.04(-0.73%)
Closed·
600998 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.395.52
52 wk Range
4.575.84
Key Statistics
Bid/Ask
5.43 / 5.44
Prev. Close
5.46
Open
5.49
Day's Range
5.39-5.52
52 wk Range
4.57-5.84
Volume
58.03M
Average Volume (3m)
47.16M
1-Year Change
8.6172%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600998 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.78
Upside
+6.64%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Jointown Pharmaceutical Group Co Ltd Company Profile

Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added services; and digital logistics and supply chain solutions. The company was founded in 1999 and is headquartered in Wuhan, China.

Employees
30169
Market
China

Compare 600998 to Peers and Sector

Metrics to compare
600998
Peers
Sector
Relationship
P/E Ratio
9.8x19.3x−0.6x
PEG Ratio
0.29−0.970.00
Price/Book
1.0x1.0x2.6x
Price / LTM Sales
0.2x0.4x3.4x
Upside (Analyst Target)
20.9%18.2%42.5%
Fair Value Upside
Unlock18.1%5.0%Unlock

Analyst Ratings

4 Buy
0 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 5.78
(+6.64% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Buy6.60+21.77%7.00MaintainOct 28, 2025
UBS
Buy7.00+29.15%7.50MaintainAug 27, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.55%
Dividend Yield
3.66%
Industry Median 1.45%
Annualized payout
0.20
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 27, 2025
EPS / Forecast
0.10 / 0.10
Revenue / Forecast
38.22B / 41.47B
EPS Revisions
Last 90 days

600998 Income Statement

People Also Watch

93.47
600118
-2.94%
19.65
600143
-2.63%
22.20
600312
+0.36%
38.05
600038
-1.30%
3.18
600170
+10.03%

FAQ

What Is the Jointown Pharm (600998) Stock Price Today?

The Jointown Pharm stock price today is 5.42

What Stock Exchange Does Jointown Pharm Trade On?

Jointown Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Jointown Pharm?

The stock symbol for Jointown Pharm is "600998."

Does Jointown Pharm Pay Dividends? What’s The Current Dividend Yield?

The Jointown Pharm dividend yield is 3.66%.

What Is the Jointown Pharm Market Cap?

As of today, Jointown Pharm market cap is 27.08B.

What Is Jointown Pharm's Earnings Per Share (TTM)?

The Jointown Pharm EPS (TTM) is 0.55.

When Is the Next Jointown Pharm Earnings Date?

Jointown Pharm will release its next earnings report on Apr 28, 2026.

From a Technical Analysis Perspective, Is 600998 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Jointown Pharm Stock Split?

Jointown Pharm has split 3 times.

How Many Employees Does Jointown Pharm Have?

Jointown Pharm has 30169 employees.

What is the current trading status of Jointown Pharm (600998)?

As of Jan 28, 2026, Jointown Pharm (600998) is trading at a price of 5.42, with a previous close of 5.46. The stock has fluctuated within a day range of 5.39 to 5.52, while its 52-week range spans from 4.57 to 5.84.

What Is Jointown Pharm (600998) Price Target According to Analysts?

The average 12-month price target for Jointown Pharm is CNY5.78, with a high estimate of CNY6.84 and a low estimate of CNY3.9. 4 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +6.64% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.